{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:49:02Z","timestamp":1780505342269,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,20]]},"DOI":"10.7759\/cureus.69794","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:54:50Z","timestamp":1726840490000},"source":"Crossref","is-referenced-by-count":3,"title":["Comparative Volumetric Analyses Following Bevacizumab Therapy for a Patient With Concomitant Glioblastoma, Meningioma, and Dural Arteriovenous Fistula: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Akihiko","family":"Teshigawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoto","family":"Kyoichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: a review of 15\u00a0years of clinical experience and future outlook","volume":"86","author":"Garcia J","year":"2020","unstructured":"Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL. Bevacizumab (Avastin\u00ae) in cancer treatment: a review of 15\u00a0years of clinical experience and future outlook. Cancer Treat Rev. 2020, 86:102017. 10.1016\/j.ctrv.2020.102017","journal-title":"Cancer Treat Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000326","article-title":"Bevacizumab and glioblastoma: past, present, and future directions","volume":"24","author":"Kim MM","year":"2018","unstructured":"Kim MM, Umemura Y, Leung D. Bevacizumab and glioblastoma: past, present, and future directions. Cancer J. 2018, 24:180-6. 10.1097\/PPO.0000000000000326","journal-title":"Cancer J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21729","article-title":"An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma","volume":"72","author":"Hasanov E","year":"2022","unstructured":"Hasanov E, Yeboa DN, Tucker MD, et al.. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin. 2022, 72:454-89. 10.3322\/caac.21729","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04544-8","article-title":"An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma","volume":"166","author":"Tanaka T","year":"2024","unstructured":"Tanaka T, Tamura R, Takei J, et al.. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma. J Neurooncol. 2024, 166:557-67. 10.1007\/s11060-023-04544-8","journal-title":"J Neurooncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199409000-00012","article-title":"Detection and quantification of vascular endothelial growth factor\/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?","volume":"35","author":"Weindel K","year":"1994","unstructured":"Weindel K, Moringlane JR, Marm\u00e9 D, Weich HA. Detection and quantification of vascular endothelial growth factor\/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?. Neurosurgery. 1994, 35:439-48. 10.1227\/00006123-199409000-00012","journal-title":"Neurosurgery"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac123","article-title":"A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma","volume":"4","author":"Kumthekar P","year":"2022","unstructured":"Kumthekar P, Grimm SA, Aleman RT, et al.. A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neurooncol Adv. 2022, 4:vdac123. 10.1093\/noajnl\/vdac123","journal-title":"Neurooncol Adv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0886-4","article-title":"Atypical and anaplastic meningiomas treated with bevacizumab","volume":"109","author":"Nayak L","year":"2012","unstructured":"Nayak L, Iwamoto FM, Rudnick JD, et al.. Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol. 2012, 109:187-93. 10.1007\/s11060-012-0886-4","journal-title":"J Neurooncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.25259\/SNI_528_2020","article-title":"The relationship between vascular endothelial growth factor and histological grade in intracranial meningioma","volume":"11","author":"Winter RC","year":"2020","unstructured":"Winter RC, Antunes AC, de Oliveira FH. The relationship between vascular endothelial growth factor and histological grade in intracranial meningioma. Surg Neurol Int. 2020, 11:328. 10.25259\/SNI_528_2020","journal-title":"Surg Neurol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S67621","article-title":"Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial","volume":"7","author":"Takano S","year":"2014","unstructured":"Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A. Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial. Onco Targets Ther. 2014, 7:1551-62. 10.2147\/OTT.S67621","journal-title":"Onco Targets Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1591019918764090","article-title":"The role of angiogenesis in dural arteriovenous fistulae: the story so far","volume":"24","author":"Bhogal P","year":"2018","unstructured":"Bhogal P, Yeo LL, Henkes H, Krings T, S\u00f6derman M. The role of angiogenesis in dural arteriovenous fistulae: the story so far. Interv Neuroradiol. 2018, 24:450-4. 10.1177\/1591019918764090","journal-title":"Interv Neuroradiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-023-00684-y","article-title":"Shaping the brain vasculature in development and disease in the single-cell era","volume":"24","author":"W\u00e4lchli T","year":"2023","unstructured":"W\u00e4lchli T, Bisschop J, Carmeliet P, Zadeh G, Monnier PP, De Bock K, Radovanovic I. Shaping the brain vasculature in development and disease in the single-cell era. Nat Rev Neurosci. 2023, 24:271-98. 10.1038\/s41583-023-00684-y","journal-title":"Nat Rev Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-004-1310-3","article-title":"Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study","volume":"47","author":"Klisch J","year":"2005","unstructured":"Klisch J, Kubalek R, Scheufler KM, Zirrgiebel U, Drevs J, Schumacher M. Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study. Neuroradiology. 2005, 47:10-7. 10.1007\/s00234-004-1310-3","journal-title":"Neuroradiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1999.91.5.0781","article-title":"Expression of angiogenic growth factors in dural arteriovenous fistula","volume":"91","author":"Uranishi R","year":"1999","unstructured":"Uranishi R, Nakase H, Sakaki T. Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg. 1999, 91:781-6. 10.3171\/jns.1999.91.5.0781","journal-title":"J Neurosurg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2037","article-title":"A pivotal role of the vascular endothelial growth factor signaling pathway in the formation of venous hypertension-induced dural arteriovenous fistulas","volume":"9","author":"Li Q","year":"2014","unstructured":"Li Q, Zhang Q, Huang QH, Fang YB, Zhang ZL, Xu Y, Liu JM. A pivotal role of the vascular endothelial growth factor signaling pathway in the formation of venous hypertension-induced dural arteriovenous fistulas. Mol Med Rep. 2014, 9:1551-8. 10.3892\/mmr.2014.2037","journal-title":"Mol Med Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.08.078","article-title":"Longitudinal imaging of tumor volume, diffusivity, and perfusion after preoperative endovascular embolization in supratentorial hemispheric meningiomas","volume":"120","author":"Gruber P","year":"2018","unstructured":"Gruber P, Schwyzer L, Klinger E, et al.. Longitudinal imaging of tumor volume, diffusivity, and perfusion after preoperative endovascular embolization in supratentorial hemispheric meningiomas. World Neurosurg. 2018, 120:e357-64. 10.1016\/j.wneu.2018.08.078","journal-title":"World Neurosurg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.11.014","article-title":"Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas","volume":"107","author":"Tirakotai W","year":"2005","unstructured":"Tirakotai W, Bertalanffy H, Liu-Guan B, Farhoud A, Sure U. Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas. Clin Neurol Neurosurg. 2005, 107:455-60. 10.1016\/j.clineuro.2004.11.014","journal-title":"Clin Neurol Neurosurg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.32.1.275-b","article-title":"Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke","volume":"32","author":"Gunsilius E","year":"2001","unstructured":"Gunsilius E, Petzer AL, Stockhammer G, K\u00e4hler CM, Gastl G. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 2001, 32:275-8. 10.1161\/01.str.32.1.275-b","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.567682","article-title":"The roles of TGF-\u03b2 signaling in cerebrovascular diseases","volume":"8","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Yang X. The roles of TGF-\u03b2 signaling in cerebrovascular diseases. Front Cell Dev Biol. 2020, 8:567682. 10.3389\/fcell.2020.567682","journal-title":"Front Cell Dev Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-016-0704-0","article-title":"A case of complete clearance of chronic subdural hematoma accompanied by recurrent glioblastoma multiforme after administration of bevacizumab","volume":"39","author":"Suzuki K","year":"2016","unstructured":"Suzuki K, Kawataki T, Kanemaru K, Mitsuka K, Ogiwara M, Sato H, Kinouchi H. A case of complete clearance of chronic subdural hematoma accompanied by recurrent glioblastoma multiforme after administration of bevacizumab. Neurosurg Rev. 2016, 39:525-9. 10.1007\/s10143-016-0704-0","journal-title":"Neurosurg Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/297366-comparative-volumetric-analyses-following-bevacizumab-therapy-for-a-patient-with-concomitant-glioblastoma-meningioma-and-dural-arteriovenous-fistula-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:54:52Z","timestamp":1726840492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/297366-comparative-volumetric-analyses-following-bevacizumab-therapy-for-a-patient-with-concomitant-glioblastoma-meningioma-and-dural-arteriovenous-fistula-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.69794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}